Dietary compliance in celiac disease

Area of Science:

• Gastroenterology
• Immunology
• Nutritional Science

Background:

• Celiac disease is an immune disorder affecting the small intestine in genetically susceptible individuals.
• Gluten ingestion triggers an immune response leading to malabsorption, diarrhea, and weight loss.
• A strict gluten-free diet (GFD) is the primary treatment, improving symptoms and nutrient absorption.

Discussion:

• GFD adherence is difficult and costly, often leading to poor compliance and incomplete symptom resolution.
• Ongoing inflammation and mucosal damage persist despite clinical improvement, increasing risks for long-term complications like malignancy.
• Assessing GFD compliance is a clinical challenge, as symptoms and antibody markers may improve while mucosal damage continues.

Key Insights:

• Histopathological recovery of the small intestinal mucosa after GFD initiation is time-dependent, sex-dependent, and age-dependent.
• Complete mucosal healing can take up to two years or longer, necessitating long-term monitoring.
• Emerging immunological studies suggest urinary and fecal peptides may indicate limited GFD compliance.

Outlook:

• Developing reliable biomarkers for GFD compliance is essential for optimizing patient outcomes.
• Further research into the mechanisms of mucosal healing and long-term complication risks is needed.
• Improving patient education and support for GFD adherence can enhance treatment efficacy and reduce long-term risks.